A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) C07K 16/28 (2006.01)
Patent
CA 2477178
A method of chronically reducing a patient's pathological inflammation via the administration of an agent that specifically binds to an alpha-4 integrin or a dimer comprising an alpha-4 integrin is disclosed. The agent provided must have a binding affinity such that administration is sufficient to suppress pathological inflammation, and the agent is administered chronically to provide long-term suppression of pathological inflammation.
L'invention concerne une méthode de réduction chronique d'une inflammation pathologique d'un patient par le biais de l'administration d'un agent se liant spécifiquement à une intégrine .alpha.-4 ou à un dimère comprenant une intégrine .alpha.-4. Cet agent doit présenter une affinité de liaison de sorte que l'administration soit suffisante pour supprimer une inflammation pathologique, et l'agent est administré de manière chronique afin d'obtenir une suppression à long terme de l'inflammation pathologique.
Taylor Julie
Yednock Ted A.
Barrigar Intellectual Property Law
Elan Pharmaceuticals Inc.
LandOfFree
Administration of agents for the treatment of inflammation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Administration of agents for the treatment of inflammation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Administration of agents for the treatment of inflammation will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2001567